A personalised pathway: cancer’s road to recovery

Stephen Taylor, Leech Professor of Pharmacology, says that as cancer treatment backlogs increase, personalised approaches are needed more than ever.

COVID-19 has caused a backlog in cancer patients seeking and receiving diagnosis and treatment. And while COVID-19 has dominated health services, cancer hasn’t gone away. Later detection means lower survival rates more, costly treatments and more palliative care.

Now, more than ever, we need to tailor treatments to the needs of the individual cancer patient based on the specific features of their specific disease.  

Our world-leading research on biomarkers and expertise in basic sciences, where we’re growing individual tumours in a lab, is helping to determine the best drugs and therapies for each patient at each stage of their treatment – making sure that every patient gets what they need, when they need it.

Recorded in August 2020